Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $41.0400 (2.65%) ($40.0100 - $41.2000) on Wed. Apr. 3, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.65% (three month average) | RSI | 56 | Latest Price | $41.0400(2.65%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2.7% a day on average for past five trading days. | Weekly Trend | ATRA advances 1.5% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -1.825% in a week (0% probabilities). VXX(-13%) UUP(-13%) TLT(-13%) VIXM(-11%) UNG(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.825% (StdDev 3.65%) | Hourly BBV | 0 () | Intraday Trend | 2.2% | | | |
|
5 Day Moving Average | $39.85(2.99%) | 10 Day Moving Average | $38.74(5.94%) | 20 Day Moving Average | $38.63(6.24%) | To recent high | -1.7% | To recent low | 44.5% | Market Cap | $3.05b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |